Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies
暂无分享,去创建一个
J. Vergnon | P. Fournel | M. Péoc'h | B. Trombert-Paviot | G. Karpathiou | Fabien Forest | F. Casteillo | C. Habougit | O. Tiffet | S. Bayle-Bleuez | M. Péoc’h
[1] K. Geisinger,et al. A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype , 2016, The American journal of surgical pathology.
[2] K. Nackaerts,et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. , 2015, The Lancet. Oncology.
[3] G. Karpathiou,et al. Pleural neoplastic pathology. , 2015, Respiratory medicine.
[4] E. Taioli,et al. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. , 2015, The Annals of thoracic surgery.
[5] J. Pairon,et al. [The French mesothelioma network from 1998 to 2013]. , 2014, Annales de pathologie.
[6] M. Papotti,et al. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma , 2014, Modern Pathology.
[7] A. Gown,et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. , 2013, Archives of pathology & laboratory medicine.
[8] Prasad S Adusumilli,et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma , 2012, Modern Pathology.
[9] C. Sima,et al. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma , 2012, Modern Pathology.
[10] R. Ramlau,et al. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] E. Brun,et al. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. , 2006, Archives of pathology & laboratory medicine.
[12] Daniele Zink,et al. Nuclear structure in cancer cells , 2004, Nature Reviews Cancer.
[13] Bignold Lp. Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis. , 2003, Histology and histopathology.
[14] D. Gisselsson. Tumour morphology--interplay between chromosome aberrations and founder cell differentiation. , 2002, Histology and histopathology.
[15] L. Thompson. Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.
[16] B. Scheithauer,et al. Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.
[17] W D Dupont,et al. Histologic grading of breast carcinoma. A reproducibility study , 1994, Cancer.
[18] E. van Marck,et al. Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA) , 1994, The Journal of pathology.
[19] S. Fuhrman,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.
[20] Jonathan I. Epstein,et al. WHO Classification of of Tumours of the Urinary System and Male Genital Organs , 2016 .
[21] Beata Kalatova,et al. Tripolar mitosis in human cells and embryos: occurrence, pathophysiology and medical implications. , 2015, Acta histochemica.
[22] F. Demirağ,et al. Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients. , 2015, Journal of cancer research and therapeutics.
[23] W. Travis. WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .
[24] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.